Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Medicamentos do grupo4: sangue

Contract value
€164,005.99
Signed on
27 January 2022
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9202527

PUBLISHED DESCRIPTION

41/376/2022

Parties involved

Place of performance
Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Boehringer Ingelheim Portugal, Lda · Tax ID 500293023
Awardee
GENERIS-FARMACEUTICA, SA · Tax ID 508107997
Awardee
ASTRAZENECA PRODUTOS FARMACÊUTICOS, LDA · Tax ID 502942240
Awardee
OM PHARMA, S.A. · Tax ID 500207410
Awardee
BAYER PORTUGAL LDA · Tax ID 500043256
Awardee
Jaba Recordati S.A. · Tax ID 500492867
Awardee
Laboratórios Pfizer, Lda · Tax ID 500162166

Values and timeline

Contract price
€164,005.99
Procedure base price
€0.00
Total effective price
Not reported on Portal BASE
Publication date
28 April 2022
Award date
27 January 2022
Signing date
27 January 2022
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2020/18 - Medicamentos do grupo 4: sangue
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5722966

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts